Hexagon Bio

Series-B+
hexagonbio.com Biotech & Healthcare 51-100
Total Funding $109M
Latest Round $62M Series-B+
Last Announced Oct 23, 2026
Investors 6 Backers
Decision Makers 6 Verified

About Hexagon Bio

Hexagon Bio is a data-driven biotech company developing targeted small molecule therapeutics.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Team Size 51-100
Tracked Since Oct 23, 2026

Web & Domain Identity

Official Website hexagonbio.com
Domain Registered Date Oct 27, 2016

Social & Network Presence

X / Twitter Profile @MHillenmeyer
LinkedIn Corporate Company Profile

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $62,000,000 · Series-B

    manilatimes.net

  2. Capital Raise

    Raised $47,000,000 · Series-A

    Backed by The Column Group, 8VC

  3. Capital Raise

    Seed announced

    Backed by 8VC, bpd partners

  4. Milestone

    Website domain registered

    hexagonbio.com

Investors & Backers

6
8VC
bpd partners
genengnews.com
LeFrak
The Column Group
Two Sigma Ventures

Funding History

3 Rounds
Series-B equity · Oct 23, 2026
$62,000,000 manilatimes.net
Series-A equity · Sep 15, 2020

Round backers: The Column Group, 8VC, LeFrak, Two Sigma Ventures

$47,000,000 goo.gl
Seed equity · Oct 31, 2017

Round backers: 8VC, bpd partners, genengnews.com

Undisclosed

Founders & Leadership

3

Colin Harvey

Vice President, Synthetic Biology Co-Founder

Work email & phone locked Unlock →

Maureen Hillenmeyer

Chief Executive Officer Co-Founder

Work email & phone locked Unlock →

Yi Tang

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts